A Case Report of Peripheral Cyanosis Associated with a Rare Adverse Reaction of Vaxzevria - AstraZeneca COVID-19 Vaccine
Abstract
In the current pandemic of SARS-CoV-2, the fast development ofvaccines was mandatory due to many deaths and cases
across theworld since the beginning of the outbreak. The European Medicines Agency (EMA) has allowed emergency use
authorization for treatment with the Vaxzevria (ChAdOx1-S, AstraZeneca) vaccines in the European Union. There are a
lot of adverse drug reactions observed during the vaccination campaign, the most common side effects are tenderness,
pain and bruising at the injection site, headache, tiredness, muscle pain, general feeling of being unwell, chills, fever, joint
pain and nausea (feeling sick), and can also rarely cause anaphylactic shock. The recognition of adverse drug reactions of
the vaccine Vaxzevria plays an important role in minimizing vaccine-induced adverse reactions. In this report, we record
and analyze a rare case of peripheral cyanosis appearing after being vaccinated, and sharing the way to resolve this
problem to contribute to the data of adverse drugs reaction regarding Vaxzevria.
